Lung cancer after treatment for breast cancer von Lorigan, Paul, Dr, Califano, Raffaele, MD, Faivre-Finn, Corinne, PhD, Howell, Anthony, Prof, Thatcher, Nick, Prof

Volltext

The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas von Rossi, Giulio, MD, Graziano, Paolo, MD, Leone, Alvaro, PhD, Migaldi, Mario, MD, PhD, Califano, Raffaele, MD

Volltext

First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study von Moliner, Laura, Zellweger, Núria, Schmid, Sabine, Bertschinger, Martina, Waibel, Christine, Cerciello, Ferdinando, Froesch, Patrizia, Mark, Michael, Bettini, Adrienne, Häuptle, Pirmin, Blum, Veronika, Holer, Lisa, Hayoz, Stefanie, Früh, Martin, Ahmed, Samreen, Bhagani, Shradha, Steele, Nicola, Gray, Hannah-Leigh, Robinson, Stephen D., Davidson, Michael, Cox, Samantha, Khalid, Taha, Geldart, Tom R., Nolan, Luke, Scott, Deborah C., Hennah, Lindsay, Newsom-Davis, Tom, Rathbone, Emma, Handforth, Catherine, Denton, Arshi, Merchant, Shairoz, Blackhall, Fiona, Mauti, Laetitia A., Califano, Raffaele, Rothschild, Sacha I.

Volltext

SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting von Greystoke, Alastair, Steele, Nicola, Arkenau, Hendrik-Tobias, Blackhall, Fiona, Md Haris, Noor, Lindsay, Colin R, Califano, Raffaele, Voskoboynik, Mark, Summers, Yvonne, So, Karen, Ghiorghiu, Dana, Dymond, Angela W, Hossack, Stuart, Plummer, Ruth, Dean, Emma

Volltext

ENP-9. KEYLYNK-013 : Pembrolizumab+CCRT Then Pembrolizumab±Olaparib vs CCRT in Limited-Stage SCLC von Terufumi Kato, Andreas Rimner, Victoria Lai, Raffaele Califano, Salma K. Jabbour, Corinne Faivre-Finn, Byoung Chul Cho, Jinming Yu, Li Yu, Bin Zhao, M. Catherine Pietanza, Lauren Byers

Volltext